Overview Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indicator: In combination with chemotherapy, with the cure of adult sufferers with domestically recurrent unresectable or metastatic triple-detrimental breast cancer who may have not gained prior chemotherapy for metastatic condition and whose tumours Convey programmed mobile Loss of life-ligand 1 (mixed good score ≥ https://keytrudacost98146.blogkoo.com/a-secret-weapon-for-keytruda-cost-55344335